Medifar SRL
1.0 FTEMedifar reported total assets of 490,803 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 1 full-time equivalent.
The score of Medifar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -41 % Total assets -34 % Headcount (avg FTE) -60 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medifar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,562 € | ||||
| Equity | 351,857 € | ||||
| Cash | 13,191 € | ||||
| EBITDA | 74,980 € | ||||
| Total assets | 490,803 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Medifar's financial analysis
- Solvency71.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medifar
Medifar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.055.258
- VAT number
- BE0428055258
- Peppol
- Registered · 0208:0428055258 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Nov 1985
- Registered office
- 8870 Izegem
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medifar (SRL) has been based in Izegem since 1985, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,562 € and equity of 351,857 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.7%, above the median of its sector (44.2%).
Companies similar to Medifar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie E. Dozot Retail sale of pharmaceutical products Andenne · balance sheet 491,246 €
- Walemapotheek Retail sale of pharmaceutical products Mechelen · balance sheet 491,415 €
- Apotheek Phlippo Retail sale of pharmaceutical products Lommel · balance sheet 489,972 €
- Arendsapotheek Retail sale of pharmaceutical products Harelbeke · balance sheet 488,654 €
- Pharmaro Retail sale of pharmaceutical products Charleroi · balance sheet 493,235 €
- Pharma-Sana Retail sale of pharmaceutical products Schaerbeek · balance sheet 487,904 €
- Secundum Artem Retail sale of pharmaceutical products Etterbeek · balance sheet 496,587 €
- Zwitserse Apotheek Retail sale of pharmaceutical products Wijnegem · balance sheet 498,014 €
Frequently asked questions about Medifar
What is the revenue of Medifar?
Medifar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medifar?
In Belgium, the VAT number is the company number prefixed with BE: BE0428055258 for Medifar, if the company is VAT-registered. Its company number (CBE) is 0428.055.258.
Where is the registered office of Medifar?
According to the CBE register, the registered office of Medifar is in 8870 Izegem.
What is the equity of Medifar?
At the close of the 2025 financial year, the equity of Medifar amounts to 351,857 €, a solvency of 71.7% of total assets.
How many people work at Medifar?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medifar?
The register lists 5 active mandates at Medifar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medifar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →